FRANKLIN, Tennessee, Sept. 28, 2018 /PRNewswire/ -- LYNCH Biologics LLC (LBIO) announced today that it has closed on a transaction with Luitpold Pharmaceuticals Inc. (LPI), under which LBIO has acquired all rights relating to GEM 21S Growth Factor Enhance Matrix, and certain additional...
from PR Newswire: //https://ift.tt/2zCGGSr
No comments:
Post a Comment